Human and animal evidence supports lower occupational exposure limits for poorly-soluble respirable particles. Letter to the editor re: 'Low-toxicity dusts: current exposure guidelines are not sufficiently protective' by Cherrie, Brosseau, Hay and Donaldson.
We commend the overall evaluation by Cherrie et al. (2013) of the current occupational exposure limits (OELs) for respirable poorly-soluble low toxicity (PSLT) particles. As described in that paper, the epidemiological studies provide compelling evidence that exposure to PSLT at the current OELs has been associated with adverse health effects, including pulmonary fibrosis and lung function deficits. In contrast to Cherrie et al. (2013), we discuss here that the chronic inhalation studies in animals also provide evidence of the adverse pulmonary effects of PSLT. Cherrie et al. view has been accepted by some regulatory institutions. For example, in the USA, the regulatory exposure limit for respirable coal mine dust is to be reduced from 2 mg m-3 as a multi-shift average concentration to 1.5 mg m-3 as a single-shift (8-hr time-weighted average) concentration, starting in August 2016 (MSHA, 2014). In addition, the rat studies provide supporting evidence with qualitatively and quantitatively consistent findings to those in the human studies. Yet, more research is needed to reduce uncertainty about the rodent dose-response models compared to humans. Such evidence is important for risk assessment and OEL development of other types of airborne particles (e.g., nanoparticles) for which sufficient human data may not be available.
Eileen D. Kuemple, National Institute for Occupational Safety and Health, Education and Information Division, 1090 Tusculum Avenue, Cincinnati, OH, 45226 USA
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.